Canada· CA-DIN-02537117

LOCAMETZ

A gallium (68ga) gozetotide product containing gallium (68ga) gozetotide, registered in Canada by NOVARTIS PHARMACEUTICALS CANADA INC. The same ATC class is registered in 11 of our 19 countries.

ATC V09IX14

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedLOCAMETZATCV09IX14REGISTER NO.CA-DIN-02537117PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Gallium (68ga) gozetotide is registered in 11 of 19 countries.

Countries holding a registration under ATC V09IX14 (gallium (68ga) gozetotide), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 7 of them publish a price we can compare per daily dose

Gallium (68ga) gozetotide · ATC V09IX14

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
GALLIUM (68Ga) GOZETOTIDE
Manufacturer
NOVARTIS PHARMACEUTICALS CANADA INC
Country
Canada (CA)
ATC code
V09IX14
ATC class
Gallium (68Ga) gozetotide
Defined daily dose
140 MBq, P
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gallium (68ga) gozetotide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gallium (68ga) gozetotide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4ab1685-95d5-4087-98c0-fb0008c59a74
GET /v1/drugs/e4ab1685-95d5-4087-98c0-fb0008c59a74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02537117",
  "form": "KIT",
  "class": "Radiopharmaceutical",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V09IX14",
  "schedule": [
    "Schedule C"
  ],
  "drug_code": "102582",
  "strengths": [
    "25 MCG"
  ],
  "ahfs_class": null,
  "substances": [
    "GALLIUM (68Ga) GOZETOTIDE"
  ],
  "product_categorization": null
}

See everything about gallium (68ga) gozetotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.